Article

Interim analysis of a phase I/IIA trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

Authors:
G.L. Maxwell
G.L. Maxwell
G.L. Maxwell
  • This person is not on ResearchGate, or hasn't claimed this research yet.
J.C. Elkas
J.C. Elkas
J.C. Elkas
  • This person is not on ResearchGate, or hasn't claimed this research yet.
Thomas P Conrads at Inova
Thomas P Conrads
Kathleen M Darcy at Women's Health Integrated Research Center at Inova Health System
Kathleen M Darcy
  • Women's Health Integrated Research Center at Inova Health System
Show all 6 authorsHide
Download citation
To read the full-text of this research, you can request a copy directly from the authors.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the authors.

ResearchGate has not been able to resolve any citations for this publication.
ResearchGate has not been able to resolve any references for this publication.